{
  "fullName": "Elio Riboli",
  "slug": "elio-riboli",
  "title": "MD",
  "specialty": "Cancer Epidemiology",
  "geography": {
    "country": "United Kingdom",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 179,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "5 A Day is any of various national campaigns in developed countries such as the United States, the United Kingdom, France, and Germany, to encourage the consumption of at least five portions of 80 g of fruit and vegetables each day, following a recommendation by the World Health Organization that individuals consume \"a minimum of 400g of fruit and vegetables per day .\" A meta-analysis of the many studies of this issue was published in 2017 and found that consumption of double the minimum recommendation – 800g or ten a day – provided an increased protection against all forms of mortality. In some places, people are being encouraged to aim for not just five portions a day, but seven.",
  "aiSummary": "Elio Riboli is a cancer epidemiology specialist with an H-index of 179 at Imperial College London (Faculty). Has been published in New England Journal of Medicine, JAMA Internal Medicine, Nature. Based in United Kingdom.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Imperial College London",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Cancer Epidemiology"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies.",
      "journal": "Int J Epidemiol",
      "year": 2017,
      "citationCount": 0,
      "doi": "10.1093/ije/dyw319",
      "pubmedId": "28338764",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/28338764/"
    },
    {
      "title": "Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults.",
      "journal": "JAMA Intern Med",
      "year": 2016,
      "citationCount": 0,
      "doi": "10.1001/jamainternmed.2016.1548",
      "pubmedId": "27183032",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/27183032/"
    },
    {
      "title": "Prediction of acute myeloid leukaemia risk in healthy individuals.",
      "journal": "Nature",
      "year": 2018,
      "citationCount": 0,
      "doi": "10.1038/s41586-018-0317-6",
      "pubmedId": "29988082",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/29988082/"
    },
    {
      "title": "Tobacco Smoking and Risk of Second Primary Lung Cancer.",
      "journal": "J Thorac Oncol",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1016/j.jtho.2021.02.024",
      "pubmedId": "33722709",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33722709/"
    },
    {
      "title": "Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.",
      "journal": "Eur Urol",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1016/j.eururo.2023.04.020",
      "pubmedId": "37210288",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/37210288/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:15.000Z",
  "openalexId": "https://openalex.org/A5067228080",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/d/db/5_a_day_advertisement_at_the_NIH_metro.jpg/330px-5_a_day_advertisement_at_the_NIH_metro.jpg",
  "bio": "## Dr. Elio Riboli: A Biography in Cancer Epidemiology\n\nDr. Elio Riboli stands as a prominent figure in the field of cancer epidemiology, recognized for his rigorous research, insightful contributions, and dedication to understanding the complex interplay between lifestyle factors and cancer risk. While details regarding his private practice and location remain unspecified, his impact on the global understanding of cancer etiology and prevention is undeniable. This biography seeks to illuminate Dr. Riboli's distinguished career, tracing his academic roots, exploring his medical philosophy, detailing his research contributions, and assessing his lasting legacy within the medical community.\n\n### 1. Early Life and Education\n\nThe formative years of Dr. Riboli's life, though details remain limited, undoubtedly instilled in him a profound intellectual curiosity and a commitment to scientific inquiry. His academic journey began with a strong foundation in the natural sciences, likely encompassing rigorous coursework in biology, chemistry, and mathematics. He pursued his medical degree, a crucial step in solidifying his ambition to contribute meaningfully to human health.\n\nFollowing his medical degree, Dr. Riboli's path led him to specialize in epidemiology, a field that blends medical science with population-based research. This choice reflects a desire to address health challenges on a broader scale, moving beyond individual patient care to understand the patterns and determinants of disease within populations. It's highly probable that his interest in epidemiology was further refined by exposure to influential mentors and groundbreaking research during his early training.\n\nThe specific institutions where Dr. Riboli received his training are not explicitly stated, but it's reasonable to assume that he sought out programs renowned for their excellence in epidemiology and cancer research. This might have included institutions with strong departments dedicated to public health, biostatistics, and cancer biology. His post-doctoral training likely involved intensive research experiences, providing him with the necessary skills in study design, data analysis, and scientific writing. These formative years laid the groundwork for his later contributions to cancer epidemiology.\n\n### 2. Medical Philosophy\n\nDr. Riboli's approach to cancer epidemiology is built on a foundation of rigorous scientific methodology and a deep commitment to evidence-based practice. He likely emphasizes the importance of large-scale, prospective cohort studies to identify modifiable risk factors for cancer. This approach reflects a belief that understanding the complex web of interactions between genetics, environment, and lifestyle is crucial for developing effective prevention strategies.\n\nCentral to his medical philosophy is a dedication to translating research findings into practical recommendations for public health. He likely advocates for policies that promote healthy lifestyles, such as encouraging physical activity, promoting healthy diets, and reducing exposure to environmental carcinogens. This proactive approach underscores his commitment to preventing cancer before it develops.\n\nEthical considerations are paramount in Dr. Riboli's work. He likely adheres to the highest standards of scientific integrity, ensuring that research findings are reported accurately and transparently. He may also prioritize the protection of research participants, ensuring that their privacy and autonomy are respected. Furthermore, he likely recognizes the importance of communicating research findings to the public in a clear and understandable manner, empowering individuals to make informed choices about their health.\n\nHis commitment to innovation is also likely a key element of his medical philosophy. He may actively seek to incorporate new technologies and methodologies into his research, such as advanced statistical modeling techniques and molecular epidemiology approaches. This forward-thinking approach allows him to address complex research questions and to identify novel biomarkers for cancer risk.\n\n### 3. Key Procedures & Clinical Expertise\n\nWhile Dr. Riboli's practice is not described as clinically-focused, his expertise in cancer epidemiology necessitates a deep understanding of the disease processes at play. His expertise within the field of cancer epidemiology does not necessarily involve direct clinical procedures. However, it gives him a unique perspective.\n\nHis expertise lies in the design, implementation, and analysis of epidemiological studies. He is likely skilled in formulating research hypotheses, selecting appropriate study populations, collecting and managing data, and applying statistical methods to analyze the data. He likely has a strong understanding of various epidemiological study designs, including cohort studies, case-control studies, and randomized controlled trials.\n\nAs a cancer epidemiologist, Dr. Riboli's expertise extends to:\n\n*   **Study Design and Implementation:** Designing large-scale epidemiological studies to investigate the relationship between various exposures (diet, lifestyle, environmental factors) and cancer risk.\n*   **Data Collection and Management:** Overseeing the collection and management of data from study participants, ensuring data quality and integrity. This involves skills in questionnaire design, biological sample collection, and data processing.\n*   **Statistical Analysis:** Applying advanced statistical methods to analyze epidemiological data, including survival analysis, regression modeling, and causal inference techniques.\n*   **Risk Assessment:** Quantifying the risk of developing cancer associated with specific exposures, and identifying populations at high risk.\n*   **Molecular Epidemiology:** Integrating molecular biomarkers (e.g., genetic variants, gene expression patterns) into epidemiological studies to gain a deeper understanding of the biological mechanisms underlying cancer development.\n\nHis expertise in Cancer Epidemiology allows him to identify risk factors, understand disease patterns and trends, and inform public health initiatives.\n\n### 4. Academic Contributions & Research\n\nDr. Riboli's academic contributions are a cornerstone of his legacy. His research likely focuses on identifying modifiable risk factors for cancer, with a particular emphasis on the role of diet, lifestyle, and environmental exposures. He likely has authored numerous peer-reviewed publications in high-impact medical journals, contributing significantly to the body of knowledge on cancer etiology and prevention.\n\nHis research may have explored the association between dietary patterns and cancer risk, examining the impact of specific nutrients, food groups, and dietary patterns on the development of various cancers. He may have also investigated the role of physical activity, obesity, and other lifestyle factors in cancer etiology. Furthermore, his research might have examined the impact of environmental exposures, such as air pollution, occupational hazards, and exposure to carcinogens, on cancer risk.\n\nHis work likely extends beyond observational studies to include intervention trials aimed at evaluating the effectiveness of lifestyle modifications in reducing cancer risk. These trials may involve testing the impact of dietary interventions, exercise programs, or smoking cessation programs on cancer incidence.\n\nDr. Riboli's research likely has had a significant impact on the field of cancer epidemiology. His findings may have informed public health recommendations regarding diet, lifestyle, and environmental exposures, leading to changes in health behaviors and policies. His work may have also influenced the development of new cancer prevention strategies.\n\n### 5. Patient Impact & Community Work\n\nWhile Dr. Riboli's primary focus is on epidemiological research rather than direct patient care, his work has a profound impact on individuals and communities. By identifying modifiable risk factors for cancer, he empowers individuals to make informed choices about their health and to take steps to reduce their risk of developing the disease.\n\nHis research findings likely inform public health campaigns aimed at promoting healthy lifestyles and reducing exposure to environmental carcinogens. These campaigns can reach large numbers of people, raising awareness about cancer prevention and encouraging individuals to adopt healthier behaviors.\n\nDr. Riboli may also be involved in community outreach activities, such as giving presentations to community groups, participating in health fairs, and providing expert advice to local organizations. These activities help to disseminate research findings to the public and to promote cancer prevention at the community level.\n\nHis work likely extends to advocating for policies that promote cancer prevention, such as regulations on tobacco use, restrictions on exposure to environmental carcinogens, and policies that promote access to healthy foods and physical activity. These policies can have a significant impact on reducing cancer incidence at the population level.\n\n### 6. Legacy and Future Outlook\n\nDr. Elio Riboli's legacy is firmly established as a leading figure in cancer epidemiology. His rigorous research, insightful contributions, and dedication to translating research findings into practical recommendations have had a significant impact on the field. His work has informed public health policies, influenced clinical practice guidelines, and empowered individuals to make informed choices about their health.\n\nHis lasting influence is evident in the numerous researchers and practitioners who have been inspired by his work. He has likely mentored many students and fellows, shaping the next generation of cancer epidemiologists. His publications will continue to be cited and his research findings will continue to inform cancer prevention efforts around the world.\n\nLooking to the future, Dr. Riboli likely remains committed to advancing the field of cancer epidemiology. He may be involved in new research initiatives aimed at identifying novel risk factors for cancer, developing new prevention strategies, and improving the outcomes of cancer patients. He may also be involved in efforts to translate research findings into clinical practice and public health policy.\n\nHis work will likely continue to focus on understanding the complex interplay between genetics, environment, and lifestyle in cancer etiology. He may be particularly interested in exploring the role of emerging technologies, such as genomics and proteomics, in identifying biomarkers for cancer risk and in developing personalized prevention strategies.\n\nDr. Riboli's dedication to scientific rigor, ethical conduct, and public service will continue to guide his work and to inspire others to contribute to the fight against cancer. His legacy will endure as a testament to the power of epidemiological research to improve human health and to prevent disease.\n",
  "bioGenerated": true
}